Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-15T15:47:09.846Z Has data issue: false hasContentIssue false

Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem

Published online by Cambridge University Press:  02 January 2018

Michael Poyurovsky
Affiliation:
Tirat Carmel Mental Health, Center and Faculty of Medicine, Israel Institute of Technology (Technion), Haifa, Israel
Abraham Weizman*
Affiliation:
Tirat Carmel Mental Health, Center and Faculty of Medicine, Israel Institute of Technology (Technion), Haifa, Israel
*
A. Weizman, Research Unit, Geha Psychiatric Hospital, PO Box 102, PetahTiqva 49100, Israel. Tel: +972 3 9258290; Fax: +972 3 9241041; e-mail: weizmana@post.tau.ac.il
Rights & Permissions [Opens in a new window]

Abstract

Information

Type
Editorials
Copyright
Copyright © Royal College of Psychiatrists, 2001 
Figure 0

Table 1In vitro binding affinities (Ki values in nM)1 of currently available atypical antipsychotics for 5-HT receptor subtypes

Figure 1

Table 2Reports on the efficacy of serotonergic agents in patients with neuroleptic-induced akathisia (NIA)

Figure 2

Fig. 1Therapeutic options for acute neuroleptic-induced akathisia.

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.